Adverse drug events associated with sodium zirconium cyclosilicate: A real-world pharmacovigilance study based on the FAERS database.

<h4>Background</h4>Sodium zirconium cyclosilicate (SZC, Lokelma) is a novel hyperkalemia therapy, but comprehensive real-world safety data are lacking. This study aimed to characterize SZC-associated adverse events (AEs) using post-marketing surveillance.<h4>Research design and met...

Full description

Bibliographic Details

Published in:	PLoS ONE
Main Authors:	Yinrui Fang, Zilun Wu, Qian Wu, Gangyi Chen
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2025-01-01
Online Access:	https://doi.org/10.1371/journal.pone.0330340